[Dysarthrias in neurologic diseases].
The clinical characteristics of dysarthria in neurological disease are reviewed in relation to the site of the lesion, giving special attention to dysarthria as an early symptom and to paroxysmal dysarthria. Iatrogenic and toxic causes of speech disorder are enumerated and the principles of diagnosis and therapy summarized.
D014150:Antipsychotic Agents / Q000009:adverse effects; D001480:Basal Ganglia Diseases / Q000175:diagnosis; D001927:Brain Diseases / Q000175:diagnosis; D002526:Cerebellar Diseases / Q000175:diagnosis; D003389:Cranial Nerve Diseases / Q000175:diagnosis; D004292:Dominance, Cerebral; D004401:Dysarthria / Q000139:chemically induced / Q000175:diagnosis*; D006801:Humans; D009136:Muscular Dystrophies / Q000175:diagnosis; D009157:Myasthenia Gravis / Q000175:diagnosis; D009422:Nervous System Diseases / Q000175:diagnosis*; D013064:Speech Disorders / Q000175:diagnosis*
D014150:Antipsychotic Agents
Dysarthrien bei neurologischen Erkrankungen.